Navigation Links
Cardiff scientists study acute infection in end-stage kidney disease patients
Date:11/13/2008

A new research study underway at Cardiff University could see a decrease in the rates of treatment failure among patients with end-stage kidney disease.

Experts in the Infection, Immunity and Inflammation Interdisciplinary Research Group at the School of Medicine have secured more than 230,000 ($375,000) from the 'Renal Discoveries - The Baxter Extramural Grant' program, to investigate the potential to safeguard susceptible patients against serious problems caused by bacterial infections.

Each year Baxter Healthcare Corporation awards the Baxter Extramural Grant for innovation, exploration and application of research to advance the knowledge of renal conditions and its treatment. With only four grants awarded world-wide each year, Cardiff University is the sole recipient of the funding for the Europe/Middle East/Africa and Russia region.

Bacterial infection among patients with end-stage kidney disease is one of the major reasons for treatment failure and mortality, particularly among patients receiving peritoneal dialysis, the form of dialysis that cleans the blood inside the body through the peritoneum.

Now, thanks to the three year funding, the multidisciplinary team sponsored by Professor of Medicine John Williams, at Cardiff University will begin studying the consequence of infection by bacteria in order to understand, and in the future better regulate, a patient's immune response to infections. The team brings together clinicians and researchers at the Peritoneal Dialysis Unit, the Institute of Nephrology, and the Department of Medical Biochemistry and Immunology.

Dr Matthias Eberl, principal investigator at the Department of Medical Biochemistry and Immunology, said: "Although peritoneal dialysis has a number of advantages such as independence from hospital and improved quality of life, infections still pose major risks to the patient. As treatment failure in these patients correlates directly with the severity of the inflammatory response and antibiotic resistance is becoming a significant problem, we need to understand why some patients are more prone to treatment failure than others."

The Baxter grant also includes a three-year visiting fellowship for a peritoneal dialysis specialist from Chang Gung Memorial Hospital in Taiwan. Dr Chan-Yu Lin will conduct his PhD studies at Cardiff University on peritoneal dialysis-related infections and receive training in early treatment of inflammation, microbiological diagnosis, and analysis of patient samples in the laboratory.

Dr Eberl said: "We are studying the immune response in peritoneal dialysis patients during episodes of bacterial peritonitis to improve current ways of infection prevention and therapy. However, the scope of our work is much wider in the context of infectious and inflammatory disease in other organs and in sepsis."

Earlier this year Dr Eberl's team together with Professor Nicholas Topley at the Department of Medical Biochemistry and Immunology were awarded a Welsh Assembly Government /Medical Research Council Health Research Partnership Award from the Wales Office of Research and Development for their work on peritoneal dialysis-related infection.


'/>"/>

Contact: Dr Matthias Eberl
eberlm@cardiff.ac.uk
Cardiff University
Source:Eurekalert

Related medicine news :

1. Scientists Unravel Mystery of Tamoxifen Resistance
2. Freezing Ovaries Preserves Fertility, Scientists Report
3. TSODs Frank Whyte Provides Negotiation Skills Training to NIH Scientists
4. Scientists Debate Dietary Supplements and Cancer Risk at AICR Conference
5. Penn scientists show how body determines optimal amount of germ-fighting B cells
6. Penn scientists map molecular regulation of fat-cell genetics
7. Scientists Make Clones of Mice Dead 16 Years
8. Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution
9. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
10. Scientists Develop New Strategy to Fight Obesity
11. Scientists Spot 4 New Alzheimers Genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... ... Dr. Jig Patel is pleased to announce openings for new patients who ... the difficulties that face people who are missing teeth , he offers education ... dentures and bridges. Not only does an implant improve oral health, it also restores ...
(Date:7/20/2017)... ... July 19, 2017 , ... Med Tech Solutions (MTS), a leading health care ... unit of Constellation Inc., a move that will help the company better serve its ... Louis, the acquisition is expected to help MTS expand its presence in ...
(Date:7/20/2017)... ... July 19, 2017 , ... Adolfson & Peterson Construction ... Josh Christensen. As a leader in healthcare construction, AP has successfully built several ... in the Midwest with Josh now on board. , Josh brings over ...
(Date:7/20/2017)... ... July 19, 2017 , ... ... may sometimes lead to, or worsen, varicose veins in some patients, according to ... while avoiding certain not-so-good practices, like excessive sitting or standing, or regularly nicking ...
(Date:7/20/2017)... ... July 20, 2017 , ... “Lucky the Buffalo and Her Adventures”: a collection of heartwarming ... Edward Bieniek. Edward Steven Bieniek Jr. was born in Toledo, Ohio. He attended ... com tech. He is married to a brilliant woman with a caring heart named ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Pace Analytical, a company of over 2,000 employees and a leader in environmental ... Sciences, further solidifying their position as the top American owned and operated environmental ... ... Analytical ... Mt Juliet, TN , enhances Pace Analytical,s capability as an innovative full ...
(Date:6/30/2017)... SAN DIEGO , June 30, 2017  AVACEN Medical (AVACEN) ... Access Journal. The research describes the use of its AVACEN ... by those suffering from fibromyalgia. ... AVACEN Medical ... Fibromyalgia is characterized by chronic widespread pain. It affects approximately 200 to ...
(Date:6/20/2017)... ROTTERDAM, Netherlands and LAGUNA HILLS, ... announced the presentation of new data that validate the ... to risk stratify patients with multiple myeloma (MM). In ... of the European Hematology Association (EHA) in ... prognostic value of MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: